Creo Medical Group (LON:CREO) Sets New 52-Week Low – Time to Sell?

Creo Medical Group PLC (LON:CREO) reached a new 52-week low during trading on Wednesday . The company traded as low as GBX 10.06 ($0.13) and last traded at GBX 10.18 ($0.13), with a volume of 3910275 shares traded. The stock had previously closed at GBX 10.88 ($0.14).

Creo Medical Group Price Performance

The firm has a market capitalization of £39.82 million, a P/E ratio of -1.56 and a beta of 0.86. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96. The business’s fifty day moving average is GBX 14.21 and its 200 day moving average is GBX 17.40.

Insider Buying and Selling at Creo Medical Group

In related news, insider Christopher Paul Hancock purchased 4,712 shares of the company’s stock in a transaction that occurred on Monday, January 20th. The shares were purchased at an average price of GBX 19 ($0.25) per share, with a total value of £895.28 ($1,171.83). 22.43% of the stock is owned by corporate insiders.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.